The global Drugs for Xerostomia market size is predicted to grow from US$ 769 million in 2025 to US$ 951 million in 2031; it is expected to grow at a CAGR of 3.6% from 2025 to 2031.

Drugs for Xerostomia include prescription and over-the-counter mouthwashes, artificial saliva or humectants to moisturize the mouth, mouthwashes specially for dry mouth, especially those containing xylitol

Xerostomia, commonly referred to as xerostomia syndrome, is the result of reduced or absent saliva flow, resulting in dry mucous membranes. Increase in radiation therapy and chemotherapy may lead to increased incidence of xerostomia, which is expected to primarily drive the xerostomia treatment market. Other factors driving the market growth include growing geriatric population base; rising prevalence of diseases such as HIV, diabetes, and Alzheimers disease.

Furthermore, the geriatric population is expected to have a significant impact on the studied market. For example, according to the 2022 World Population Prospects, the global population aged 65 and over will be 771 million in 2022, and it is expected to reach 994 million by 2030 and 1.6 billion by 2050. Older adults often experience dry mouth, which is often associated with reduced salivary gland activity. Medication use, chronic disease, and radiation therapy to the head and neck area have all been cited as causes of xerostomia in older adults.

Infinity Market Research newest research report, the ?Drugs for Xerostomia Industry Forecast? looks at past sales and reviews total world Drugs for Xerostomia sales in 2024, providing a comprehensive analysis by region and market sector of projected Drugs for Xerostomia sales for 2025 through 2031. With Drugs for Xerostomia sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Drugs for Xerostomia industry.

This Insight Report provides a comprehensive analysis of the global Drugs for Xerostomia landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Drugs for Xerostomia portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Drugs for Xerostomia market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Drugs for Xerostomia and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Drugs for Xerostomia.

This report presents a comprehensive overview, market shares, and growth opportunities of Drugs for Xerostomia market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

    Spray
    Oral Liquid
    Buccal Tablet
    Mouth Wash

Segmentation by Application:

    Supermarket
    Hospital
    Other

This report also splits the market by region:

    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the companys coverage, product portfolio, its market penetration.

    Concordia
    AMICI
    Aurobindo Pharma Ltd
    Impax Labs
    Lannett Co Inc
    Padagis Us
    Amneal Pharmaceuticals Pvt. Ltd.
    Bausch Health Companies Inc.
    GSK
    Jazz Pharmaceuticals plc
    Mission Pharmacal Company
    OraCoat
    Cumberland Pharmaceuticals, Inc.
    Fleet, C.B., Company
    Parnell Pharmaceuticals, Inc
    Clinigen
    Sun Pharm

Key Questions Addressed in this Report

What is the 10-year outlook for the global Drugs for Xerostomia market?
What factors are driving Drugs for Xerostomia market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Drugs for Xerostomia market opportunities vary by end market size?
How does Drugs for Xerostomia break out by Type, by Application?